Literature DB >> 22005871

Management of acetabular bone loss in revision total hip arthroplasty.

Gregory K Deirmengian1, Benjamin Zmistowski, Joseph T O'Neil, William J Hozack.   

Abstract

Most acetabular revisions can be managed with a hemispherical component with screw fixation. Areas of segmental bone loss that preclude acetabular component stability may be managed with structural allograft or second-generation porous metal augments. Acetabular cages have a limited application but can be a useful tool in the management of massive bone loss and pelvic discontinuity.

Entities:  

Mesh：

Year:  2011        PMID： 22005871     DOI： 10.2106/JBJS.J.01197

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN： 0021-9355            Impact factor:   5.284


  17 in total

1.  Revision total hip arthroplasty combined with subtrochanteric shortening osteotomy: case report.

Authors:  Motoki Sonohata; Masaru Kitajima; Syunsuke Kawano; Hidefumi Honke; Takao Hotokebuchi; Masaaki Mawatari
Journal:  Open Orthop J       Date:  2014-03-07

2.  Supercharging irradiated allografts with mesenchymal stem cells improves acetabular bone grafting in revision arthroplasty.

Authors:  Philippe Hernigou; Jacques Pariat; Steffen Queinnec; Yasuhiro Homma; Charles Henri Flouzat Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2014-02-09       Impact factor: 3.075

3.  Allografts supercharged with bone-marrow-derived mesenchymal stem cells possess equivalent osteogenic capacity to that of autograft: a study with long-term follow-ups of human biopsies.

Authors:  Philippe Hernigou; Arnaud Dubory; François Roubineau; Yasuhiro Homma; Charles Henri Flouzat-Lachaniette; Nathalie Chevallier; Helene Rouard
Journal:  Int Orthop       Date:  2016-08-24       Impact factor: 3.075

Review 4.  Particle disease: biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty.

Authors:  Jiri Gallo; Stuart B Goodman; Yrjö T Konttinen; Milan Raska
Journal:  Innate Immun       Date:  2012-06-29       Impact factor: 2.680

5.  Risk factors for early revision after total hip arthroplasty.

Authors:  Christopher J Dy; Kevin J Bozic; Ting Jung Pan; Timothy M Wright; Douglas E Padgett; Stephen Lyman
Journal:  Arthritis Care Res (Hoboken)       Date:  2014-06       Impact factor: 4.794

6.  Tritanium acetabular wedge augments: short-term results.

Authors:  Camilo Restrepo; Snir Heller; Antonia F Chen
Journal:  Ann Transl Med       Date:  2016-06

7.  Implant survival and radiographic outcome of total hip replacement in patients less than 20 years old.

Authors:  Masako Tsukanaka; Vera Halvorsen; Lars Nordsletten; Ingvild Ø EngesæTer; Lars B EngesæTer; Anne Marie Fenstad; Stephan M Röhrl
Journal:  Acta Orthop       Date:  2016-07-20       Impact factor: 3.717

8.  Blockade of NF-κB and MAPK pathways by ulinastatin attenuates wear particle-stimulated osteoclast differentiation in vitro and in vivo.

Authors:  Jiang-Ying Ru; Hai-Dong Xu; Dai Shi; Jun-Bo Pan; Xiao-Jin Pan; Yan-Fen Wang
Journal:  Biosci Rep       Date:  2016-10-27       Impact factor: 3.840

9.  Multiple Acetabular Revisions in THA - Poor Outcome Despite Maximum Effort.

Authors:  O Bischel; J B Seeger; Jb Seeger; M Krüger; M Krüge; R G Bitsch; Bg Bitsch
Journal:  Open Orthop J       Date:  2012-11-16

10.  Acetabular reconstruction with the Burch-Schneider antiprotrusio cage and bulk allografts: minimum 10-year follow-up results.

Authors:  Dario Regis; Andrea Sandri; Ingrid Bonetti
Journal:  Biomed Res Int       Date:  2014-05-21       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.